Business Wire (January 12, 2004)
Permanent Link:
http://vlex.com/vid/orthovita-vitoss-scaffold-foam-graft-54649907
Id. vLex: VLEX-54649907
Acceda a este documento
y pruebe vLex GRATIS durante 3 días
Orthovita Announces FDA 510k Clearance to Market VITOSS Scaffold FOAM Bone Graft Material.
Business Editors/Health/Medical Writers
MALVERN, Pa.--(BUSINESS WIRE)--Jan. 12, 2004 Clearance of New Biomaterial Platform Co-developed with Kensey Nash Corporation Expected to Enable Commercialization of a Wide Array of New Products to Treat Bone Defects Caused by Injury or Trauma Orthovita, Inc. (NASDAQ NM:VITA), a leading developer of orthopaedic biomaterials, reported today it has received 510(k) F...Try vLex for FREE for 3 days
Access legal information from United States including:
Try vLex without any commitment for 3 days and see why you need it.
3
days of Free Access
If you are already a vLex customer, Access Here